BR0017340A - Treatment of trauma and other indications - Google Patents

Treatment of trauma and other indications

Info

Publication number
BR0017340A
BR0017340A BR0017340-1A BR0017340A BR0017340A BR 0017340 A BR0017340 A BR 0017340A BR 0017340 A BR0017340 A BR 0017340A BR 0017340 A BR0017340 A BR 0017340A
Authority
BR
Brazil
Prior art keywords
trauma
treatment
indications
affected
area
Prior art date
Application number
BR0017340-1A
Other languages
Portuguese (pt)
Inventor
Richard Franklin
Didier S P Cowling
Jeffrey A Hubbell
Petra Van De Wetering
Original Assignee
Phairson Medical Inc
Eidgenoess Tech Hochschule
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phairson Medical Inc, Eidgenoess Tech Hochschule filed Critical Phairson Medical Inc
Publication of BR0017340A publication Critical patent/BR0017340A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Abstract

"TRATAMENTO DE TRAUMA E OUTRAS INDICAçõES". é fornecido um método para tratar uma área afetada por um trauma, tal como uma ferida corneana ou trauma interno, compreendendo administrar na área afetada uma quantidade eficaz de tratamento de trauma de uma composição compreendendo um polímero polianiónico."TREATMENT OF TRAUMA AND OTHER INDICATIONS". A method is provided for treating an area affected by trauma, such as a corneal wound or internal trauma, comprising administering to the affected area an effective trauma treatment amount of a composition comprising a polyanionic polymer.

BR0017340-1A 2000-08-23 2000-08-23 Treatment of trauma and other indications BR0017340A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/023072 WO2002015913A1 (en) 2000-08-23 2000-08-23 Treatment of trauma, and other indications

Publications (1)

Publication Number Publication Date
BR0017340A true BR0017340A (en) 2003-12-09

Family

ID=21741703

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0017340-1A BR0017340A (en) 2000-08-23 2000-08-23 Treatment of trauma and other indications

Country Status (6)

Country Link
EP (1) EP1318819A4 (en)
JP (1) JP2004506688A (en)
AU (1) AU2000269264A1 (en)
BR (1) BR0017340A (en)
CA (1) CA2425206A1 (en)
WO (1) WO2002015913A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1358883E (en) * 2002-04-30 2007-10-01 Sifi Spa Re-epithelializing pharmaceutical compositions containing xanthan gum
US7465463B2 (en) * 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
WO2005065079A2 (en) 2003-11-10 2005-07-21 Angiotech International Ag Medical implants and fibrosis-inducing agents
EP1726643A1 (en) * 2005-05-27 2006-11-29 Direvo Biotech AG Method for the provision, identification and selection of proteases with altered sensitivity to activity-modulating substances
CA2923753C (en) 2013-09-19 2021-10-12 Terumo Corporation Polymer particles
WO2015042462A1 (en) * 2013-09-19 2015-03-26 Microvention, Inc. Polymer films
CN105916495B (en) 2013-11-08 2019-11-12 泰尔茂株式会社 Polymer beads
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
CN109789239B (en) 2016-09-28 2021-01-22 泰尔茂株式会社 Polymer particles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004681A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic solution
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
DE4209722C3 (en) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Dripable gel for ophthalmology
US6039940A (en) * 1996-10-28 2000-03-21 Ballard Medical Products Inherently antimicrobial quaternary amine hydrogel wound dressings
US6730323B1 (en) * 1996-12-18 2004-05-04 Care Teck Laboratories, Inc. Microclysmic gel for treatment of tissue trauma and burns
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
AU2479099A (en) * 1998-01-28 1999-08-16 Seatrace Pharmaceuticals, Inc. Topical vasodilatory gel composition and methods of use and production
WO2000049991A2 (en) * 1999-02-23 2000-08-31 Phairson Medical Inc. Treatment of trauma

Also Published As

Publication number Publication date
EP1318819A4 (en) 2006-03-15
EP1318819A1 (en) 2003-06-18
WO2002015913A1 (en) 2002-02-28
JP2004506688A (en) 2004-03-04
AU2000269264A1 (en) 2002-03-04
CA2425206A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
BR0210941A (en) Substituted Oxazolidinone Combination Therapy
UA41989C2 (en) Pharmaceutical composition in form of gel for treating skin diseases and method for treating infected skin
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
NZ597106A (en) Ophthalmic compositions comprising carnitine and methods for treating eyes
ATE375341T1 (en) THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OR PREVENTION OF PAIN
MXPA02005173A (en) Remedies for diseases in association with decrease in bone mass.
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BR0209327A (en) Composition for treatment of drug-induced constipation
BR0316776A (en) Topical anti-infectious formula
TWI367751B (en) Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
PT1056454E (en) UTILIZATION OF MACROLID COMPOUNDS FOR THE TREATMENT OF GLAUCOMA
BR0017340A (en) Treatment of trauma and other indications
KR920017655A (en) Pharmaceutical compositions for promoting the treatment of wounds
AR020660A1 (en) ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF EYES, EARS AND NOSE
BR0011578A (en) Use of citalopram s-enantiomer to treat general anxiety disorder or panic attacks
BRPI0413413A (en) Piperidine-substituted phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
BRPI0410654A (en) compound, pharmaceutical composition, use of a compound, method for treating a disorder of a patient, and process for the preparation of a compound
WO2000049991A3 (en) Treatment of trauma
ATE369856T1 (en) METHOD FOR TREATING GLAUCOMA
BR0015781A (en) Pharmaceutical composition for treatment of diseases associated with decreased bone mass
BR0212151A (en) Use of compounds to treat conditions resulting from corneal nerve damage following lasik and other eye surgery or trauma
BR0016720A (en) Use of trimebutin to treat pain
ES2171147A1 (en) Preparation for veterinary use for prevention of otitis
ATE271867T1 (en) TREATMENT OF URINARY INCONTINENCE AND COMPOSITION THEREOF
AR015537A1 (en) USE OF BRINZOLAMIDE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR PREVENT RETINA EDEMA.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.